Cargando…

Enhancement of Antitumor Activity of Cisplatin on Human Gastric Cancer Cells in vitro and in vivo by Buthionine Sulfoximine

An attempt was made to evaluate the enhancement of the antitumor activity of cisplatin (DDP) by buthionine sulfoximine (BSO) in vitro and in vivo. In the in vitro study, pre‐treatment with BSO (5, 10 and 25 mM) increased the antitumor activity of DDP against the gastric cancer cell lines MKN‐28 and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saikawa, Yoshiro, Kubota, Tetsuro, Kuo, Tsong‐Hong, Furukawa, Toshiharu, Tanino, Hirokazu, Watanabe, Masahiko, Ishibiki, Kyuya, Kitajima, Masaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1993
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919204/ https://www.ncbi.nlm.nih.gov/pubmed/8370654 http://dx.doi.org/10.1111/j.1349-7006.1993.tb02045.x

Ejemplares similares

Single‐cell Suspension Assay with an MTT End Point Is Useful for Evaluating the Optimal Adjuvant Chemotherapy for Advanced Gastric Cancer
por: Saikawa, Yoshiro, et al.
Publicado: (1994)

In vivo Antitumor Activity of Hexamethylmelamine against Human Breast, Stomach and Colon Carcinoma Xenografts
por: Tanino, Hirokazu, et al.
Publicado: (1995)

Production of Human Immunoglobulin G Reactive against Human Cancer in Tumor‐bearing Mice with Severe Combined Immunodeficiency Reconstituted with Human Splenic Tissues
por: Furukawa, Toshiharu, et al.
Publicado: (1992)

Effects of Buthionine Sulfoximine Treatment on Cellular Glutathione Levels and Cytotoxicities of Cisplatin, Carboplatin and Radiation in Human Stomach and Ovarian Cancer Cell Lines(*): – Glutathione, Buthionine Sulfoximine, Cytotoxicity –
por: Lee, Kyung Shik, et al.
Publicado: (1992)

Depletion of tumour versus normal tissue glutathione by buthionine sulfoximine.
por: Lee, F. Y., et al.
Publicado: (1987)

l-Buthionine Sulfoximine Detection and Quantification in Polyurea Dendrimer Nanoformulations
por: Mota, Pedro, et al.
Publicado: (2019)

Nifurtimox Is Effective Against Neural Tumor Cells and Is Synergistic with Buthionine Sulfoximine
por: Du, Michael, et al.
Publicado: (2016)

High Human IgG Levels in Severe Combined Immunodeficient Mouse Reconstituted with Human Splenic Tissues from Patients with Gastric Cancer
por: Kubota, Tetsuro, et al.
Publicado: (1992)

Combined effect of buthionine sulfoximine and cyclophosphamide upon murine tumours and bone marrow.
por: Ono, K., et al.
Publicado: (1986)

In vivo production of different chloroform metabolites: effect of phenobarbital and buthionine sulfoximine pretreatment.
por: Gemma, S, et al.
Publicado: (1994)

The responses of Ht22 cells to oxidative stress induced by buthionine sulfoximine (BSO)
por: Chen, Jun, et al.
Publicado: (2005)

3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells
por: Lee, Minjong, et al.
Publicado: (2017)

Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis
por: Lewis-Wambi, Joan S, et al.
Publicado: (2008)

Glutathione Depletion by L-Buthionine-S,R-Sulfoximine Induces Apoptosis of Cardiomyocytes through Activation of PKC-δ
por: Kim, Young-Ae, et al.
Publicado: (2013)

Protective Effect of Tempol on Buthionine Sulfoximine-Induced Mitochondrial Impairment in Hippocampal Derived HT22 Cells
por: Salvi, Ankita, et al.
Publicado: (2016)

The effects of buthionine sulfoximine treatment on diaphragm contractility and SERCA pump function in adult and middle aged rats
por: Smith, Ian C, et al.
Publicado: (2015)

Correction to: Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis
por: Lewis-Wambi, Joan S., et al.
Publicado: (2018)

Paradoxical Enhancement of Tumor Growth in Mice with Severe Combined Immunodeficiency which Produce a Human Immunoglobulin G Reactive against Tumor Cells
por: Furukawa, Toshiharu, et al.
Publicado: (1994)

The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma
por: Tagde, A, et al.
Publicado: (2014)

Polyurea Dendrimer Folate-Targeted Nanodelivery of l-Buthionine Sulfoximine as a Tool to Tackle Ovarian Cancer Chemoresistance
por: Cruz, Adriana, et al.
Publicado: (2020)

Multidrug Resistance-Associated Protein 1 (MRP1) mediated vincristine resistance: effects of N-acetylcysteine and Buthionine Sulfoximine
por: Akan, Ilhan, et al.
Publicado: (2005)

Adenosine Improves Mitochondrial Function and Biogenesis in Friedreich’s Ataxia Fibroblasts Following L-Buthionine Sulfoximine-Induced Oxidative Stress
por: Lew, Sze Yuen, et al.
Publicado: (2023)

PKCδ Sensitizes Neuroblastoma Cells to L-Buthionine-Sulfoximine and Etoposide Inducing Reactive Oxygen Species Overproduction and DNA Damage
por: Marengo, Barbara, et al.
Publicado: (2011)

Synergistic Apoptosis of CML Cells by Buthionine Sulfoximine and Hydroxychavicol Correlates with Activation of AIF and GSH-ROS-JNK-ERK-iNOS Pathway
por: Chowdhury, Avik Acharya, et al.
Publicado: (2013)

Iron-based metal-organic framework co-loaded with buthionine sulfoximine and oxaliplatin for enhanced cancer chemo-ferrotherapy via sustainable glutathione elimination
por: Rao, Zhiping, et al.
Publicado: (2023)

Antitumor Activity of Fluoropyrimidines and Thymidylate Synthetase Inhibition
por: Kubota, Tetsuro, et al.
Publicado: (1991)

Antitumor Activity and Pharmacokinetics of a Morpholino‐anthracycline Derivative (KRN8602) against Human Breast Carcinoma Xenografts Serially Transplanted into Nude Mice
por: Kubota, Tetsuro, et al.
Publicado: (1990)

Cyclin D1 Antisense Oligonucleotide Inhibits Cell Growth Stimulated by Epidermal Growth Factor and Induces Apoptosis of Gastric Cancer Cells
por: Saikawa, Yoshiro, et al.
Publicado: (2001)

UCN‐01 (7‐Hydroxystaurosporine) Enhances 5‐Fluorouracil Cytotoxicity through Down‐regulation of Thymidylate Synthetase Messenger RNA
por: Abe, Sadanori, et al.
Publicado: (2000)

BIM(EL) is a key effector molecule in oxidative stress-mediated apoptosis in acute myeloid leukemia cells when combined with arsenic trioxide and buthionine sulfoximine
por: Tanaka, Yukie, et al.
Publicado: (2014)

"Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence
por: Savarino, Andrea, et al.
Publicado: (2009)

Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE
por: Delbart, Wendy, et al.
Publicado: (2023)

Improvement of Therapeutic Effect by Using Fab' Fragment in the Treatment of Carcinoembryonic Antigen‐positive Human Solid Tumors with Adriamycinentrapped Immunoliposomes
por: Uyama, Ichiro, et al.
Publicado: (1994)

UCN‐01 (7‐Hydoxystaurosporine) Inhibits in vivo Growth of Human Cancer Cells through Selective Perturbation of G1 Phase Checkpoint Machinery
por: Abe, Sadanori, et al.
Publicado: (2001)

Synthesis and Transformations of NH‐Sulfoximines
por: Andresini, Michael, et al.
Publicado: (2021)

Mode of Action of Estra‐1,3,5(10)‐triene‐3,17β‐diol 3‐Benzoate 17‐((4‐(4‐Bis(2‐chloroethyl)amino)phenyl)‐1‐oxobutoxy)acetate) on Human Breast Carcinoma Xenografts in Nude Mice
por: Kubota, Tetsuro, et al.
Publicado: (1988)

Systemic L-Buthionine -S-R-Sulfoximine Treatment Increases Plasma NGF and Upregulates L-cys/L-cys2 Transporter and γ-Glutamylcysteine Ligase mRNAs Through the NGF/TrkA/Akt/Nrf2 Pathway in the Striatum
por: Valdovinos-Flores, Cesar, et al.
Publicado: (2019)

Novel Pieces for the Emerging Picture of Sulfoximines in Drug Discovery: Synthesis and Evaluation of Sulfoximine Analogues of Marketed Drugs and Advanced Clinical Candidates
por: Sirvent, Juan Alberto, et al.
Publicado: (2017)

Silver-mediated Room Temperature Reactions for the Synthesis of N-α-Ketoacyl Sulfoximines and N-α,β-Unsaturated Acyl Sulfoximines
por: Gupta, Ria, et al.
Publicado: (2023)

Preventive Effect of Matrix Metalloproteinase Inhibitor, R‐94138, in Combination with Mitomycin C or Cisplatin on Peritoneal Dissemination of Human Gastric Cancer Cell Line TMK‐1 in Nude Mice
por: Igarashi, Naoki, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_jcm651j5flee8th6i05tfd4d6k